| Literature DB >> 36009996 |
Kesia Esther da Silva1,2, Gleyce Hellen de Almeida de Souza1, Quézia Moura3, Luana Rossato1, Letícia Cristina Limiere4, Nathalie Gaebler Vasconcelos4, Simone Simionatto1.
Abstract
This study evaluated the scope and genetic basis of polymyxin-resistant Klebsiella aerogenes in Brazil. Eight polymyxin-resistant and carbapenemase-producing K. aerogenes strains were isolated from patients admitted to the ICU of a tertiary hospital. Bacterial species were identified by automated systems and antimicrobial susceptibility profile was confirmed using broth microdilution. The strains displayed a multidrug resistant profile and were subjected to whole-genome sequencing. Bioinformatic analysis revealed a variety of antimicrobial resistance genes, including the blaKPC-2. No plasmid-mediated colistin resistance gene was identified. Nonetheless, nonsynonymous mutations in mgrB, pmrA, pmrB, and eptA were detected, justifying the colistin resistance phenotype. Virulence genes encoding yersiniabactin, colibactin, and aerobactin were also found, associated with ICEKp4 and ICEKp10, and might be related to the high mortality observed among the patients. In fact, this is the first time ICEKp is identified in K. aerogenes in Brazil. Phylogenetic analysis grouped the strains into two clonal groups, belonging to ST93 and ST16. In summary, the co-existence of antimicrobial resistance and virulence factors is deeply worrying, as it could lead to the emergence of untreatable invasive infections. All these factors reinforce the need for surveillance programs to monitor the evolution and dissemination of multidrug resistant and virulent strains among critically ill patients.Entities:
Keywords: Enterobacteriaceae; ICEKp; colistin-resistance; genetic mechanisms; intensive care unit; whole genome sequencing
Year: 2022 PMID: 36009996 PMCID: PMC9405322 DOI: 10.3390/antibiotics11081127
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Clinical characteristics of patients hospitalized in ICU and infected by polymyxin-resistant K. aerogenes.
| Strain | Age/Sex | Clinical Isolates | Data of Isolation | Length of Stay (Days) | Place Prior to Admission | Clinical Signs of Sepsis | Outcome | Exposure to Antibiotics | Prior PMB (Days) |
|---|---|---|---|---|---|---|---|---|---|
| 6 | 31/F | Blood | 08/09/2016 | 29 | Home | Yes | Death | Carbapenems/Cephalosporins/ | 8 |
| 13 | 48/F | Tracheal aspirates | 09/02/2016 | 87 | Another hospital | No | Recovery | Carbapenems/Cephalosporins | - |
| 15 | 50/M | Urine | 09/12/2016 | 84 | Another hospital | No | Recovery | Aminoglycosides/ Carbapenems | - |
| 21 | 38/M | Tracheal aspirates | 09/18/2016 | 49 | Another hospital | Yes | Death | Aminoglycosides/ Carbapenems | - |
| 22 | 76/M | Blood | 10/03/2016 | 19 | Another hospital | Yes | Death | Aminoglycosides/ Carbapenems | - |
| 39 | 48/F | Blood | 10/05/2016 | 16 | Another hospital | Yes | Death | Carbapenems/ Cephalosporins/ | 6 |
| 40 | 36/F | Blood | 10/11/2016 | 29 | Home | Yes | Death | Carbapenems/Glycycycline/ | - |
| 46 | 33/F | Urine | 10/23/2016 | 35 | Home | No | Recovery | Aminoglycosides/Cephalosporins/ | - |
Abbreviations: M—Male; F—Female; ICU—Intensive care unit; PMB—polymyxin B.
Figure 1Maximum-likelihood phylogenetic tree and gene content of polymyxin-resistant K. aerogenes strains isolated from ICU. Black bars represent the presence of resistance genes, blue bars the virulence genes and red bars the plasmid profile, predicted by the ResFinder 4.1 program.
Phenotypic characterization of polymyxin-resistant K. aerogenes isolates.
| Strain | ST | MICs (mg/L) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAZ | CTX | CRO | FEP | ATM | IPM | MEM | ETP | AMK | GEN | CIP | LEV | PMB | ||
| 6 | 93 | >256 (R) | >256 (R) | >256 (R) | >256 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 64 (R) | >32 (R) | 16 (R) | 8 (R) | 16 (R) |
| 13 | 93 | >256 (R) | >256 (R) | >256 (R) | >256 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 64 (R) | >32 (R) | 16 (R) | 8 (R) | 32 (R) |
| 15 | 93 | >256 (R) | >256 (R) | >256 (R) | 128 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 32 (I) | >32 (R) | 16 (R) | 8 (R) | 16 (R) |
| 21 | 93 | >256 (R) | >256 (R) | 128 (R) | >256 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 32 (I) | >32 (R) | 16 (R) | 8 (R) | 32 (R) |
| 22 | 93 | 128 (R) | >256 (R) | >256 (R) | 128 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 32 (I) | >32 (R) | 16 (R) | 8 (R) | 32 (R) |
| 39 | 16 | >256 (R) | >256 (R) | >256 (R) | >256 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 64 (R) | >32 (R) | 16 (R) | 8 (R) | 8 (R) |
| 40 | 16 | >256 (R) | >256 (R) | 128 (R) | >256 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 64 (R) | >32 (R) | 16 (R) | 8 (R) | 8 (R) |
| 46 | 16 | 128 (R) | >256 (R) | >256 (R) | >256 (R) | >32 (R) | >16 (R) | >16 (R) | >32 (R) | 64 (R) | >32 (R) | 16 (R) | 8 (R) | 8 (R) |
Abbreviations: MIC—minimal inhibitory concentration; CAZ—ceftazidime; CTX—cefotaxime; CRO—ceftriaxone; FEP—cefepime; ATM—aztreonam; IMP—imipenem; MEM—meropenem; ETP—ertapenem; AMK—amikacin; GEN—gentamicin; CIP—ciprofloxacin; LEV—levofloxacin; PMB—polymyxin B. Interpretive categories of MICs: I, intermediate; R, resistant; S, susceptible.
Figure 2Flowchart of the study design.
Evaluation of deleterious mutations related to polymyxin resistant in K. aerogenes strains.
| Strains | ST | Genes | ENA | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |||
| 6 | 93 | M1V, G37S | - | - | - | - | T296S | - | ERR4298505 |
| 13 | 93 | M1V, G37S | - | - | - | - | T296S | - | ERR4298507 |
| 15 | 93 | M1V, G37S | - | - | - | - | T296S | - | ERR4298508 |
| 21 | 93 | M1V | - | - | - | - | T296S | - | ERR4298509 |
| 22 | 93 | M1V | - | - | - | - | T296S | - | ERR4298510 |
| 39 | 16 | M1V | - | - | - | T157P | - | - | ERR4298511 |
| 40 | 16 | M1V | - | - | Q140L, G145E | R256G | L252A, P257A | G127A, F353V, A462G | ERR4298512 |
| 46 | 16 | M1V | - | - | - | T157P | - | - | ERR4298513 |
ENA—European Nucleotide Archive.